Skip to main content

Table 3 Percentages refer to complete responses

From: Study Protocol. ECSSIT – Elective Caesarean Section Syntocinon® Infusion Trial. A multi-centre randomised controlled trial of oxytocin (Syntocinon®) 5 IU bolus and placebo infusion versus oxytocin 5 IU bolus and 40 IU infusion for the control of blood loss at elective caesarean section

  All
n = 365 (%)
Obstetricians
n = 179 (%)
Anaesthetists
n = 186 (%)
Slow bolus 5 IU oxytocin 324 (89.5) 153 (86.4) 171 (92.4)
Slow bolus 10 IU oxytocin 44 (12.1) 28 (15.6) 16 (8.6)
Additional 5 IU bolus if clinically indicated 61 (17.0) 17 (9.5) 44 (23.5)
Routine use of oxytocin infusion 72 (19.8) 33 (18.4) 39 (21.1)
Selective use of oxytocin infusion 289 (79.8) 145 (81.0) 144 (78.7)
30 IU oxytocin infusion 158 (43.3) 83 (46.4) 76 (40.9)
40 IU oxytocin infusion 192 (53.3) 90 (50.8) 102 (55.0)
  1. Approaches to the use of oxytocin at the time of caesarean section